Witte H - Search Results

1

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.

Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U. Shumilov E, et al. Among authors: witte h. Ann Hematol. 2024 May;103(5):1587-1599. doi: 10.1007/s00277-023-05587-7. Epub 2024 Jan 9. Ann Hematol. 2024. PMID: 38194088 Free PMC article.

2

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma.

Witte H, Biersack H, Kopelke S, Rades D, Merz H, Bernard V, Lehnert H, Gebauer N. Witte H, et al. Oncotarget. 2018 Apr 13;9(28):19613-19622. doi: 10.18632/oncotarget.24701. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29731969 Free PMC article.

3

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma.

Witte H, Biersack H, Kopelke S, Rades D, Merz H, Bernard V, Lehnert H, Fetscher S, Gebauer N. Witte H, et al. Br J Haematol. 2019 Mar;184(5):869-873. doi: 10.1111/bjh.15198. Epub 2018 May 22. Br J Haematol. 2019. PMID: 29785776 Free article. Clinical Trial. No abstract available.

4

Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.

Witte HM, Riecke A, Mayer T, Bartscht T, Rades D, Lehnert H, Merz H, Fetscher S, Biersack H, Gebauer N. Witte HM, et al. J Cancer Res Clin Oncol. 2019 Jan;145(1):129-136. doi: 10.1007/s00432-018-2772-8. Epub 2018 Oct 16. J Cancer Res Clin Oncol. 2019. PMID: 30327940

5

Multifocal and hormone-dependent epithelioid hemangioendothelioma with osteolysis of the second cervical vertebral body: report of an unprecedented surgical approach by using autologous bone graft.

Witte HM, Riecke A, Mayer T, Hackenbroch C, Steinestel K, Gebauer N, Puckhaber D, Mathieu R, Mauer UM, Schulz C. Witte HM, et al. Br J Neurosurg. 2023 Aug;37(4):816-824. doi: 10.1080/02688697.2019.1668542. Epub 2019 Oct 4. Br J Neurosurg. 2023. PMID: 31583911

6

Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.

Witte HM, Merz H, Biersack H, Bernard V, Riecke A, Gebauer J, Lehnert H, von Bubnoff N, Feller AC, Gebauer N. Witte HM, et al. Br J Haematol. 2020 Apr;189(2):257-268. doi: 10.1111/bjh.16342. Epub 2020 Jan 20. Br J Haematol. 2020. PMID: 31958882 Free article.

7

Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate.

Witte HM, Gebauer N, Lappöhn D, Umathum VG, Riecke A, Arndt A, Steinestel K. Witte HM, et al. Cancers (Basel). 2020 Apr 3;12(4):873. doi: 10.3390/cancers12040873. Cancers (Basel). 2020. PMID: 32260165 Free PMC article.

8

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation.

Witte HM, Bonorden B, Riecke A, Biersack H, Steinestel K, Merz H, Feller AC, Bernard V, Fetscher S, von Bubnoff N, Gebauer N. Witte HM, et al. Cancers (Basel). 2020 Apr 9;12(4):921. doi: 10.3390/cancers12040921. Cancers (Basel). 2020. PMID: 32283706 Free PMC article.

9

Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.

Rieken J, Bernard V, Witte HM, Peter W, Merz H, Olschewski V, Hertel L, Lehnert H, Biersack H, von Bubnoff N, Feller AC, Gebauer N. Rieken J, et al. Among authors: witte hm. Br J Haematol. 2021 Apr;193(1):138-149. doi: 10.1111/bjh.17083. Epub 2020 Sep 18. Br J Haematol. 2021. PMID: 32945554 Free article.

10

The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme.

Witte HM, Riecke A, Steinestel K, Schulz C, Küchler J, Gebauer N, Tronnier V, Leppert J. Witte HM, et al. Br J Neurosurg. 2024 Apr;38(2):404-410. doi: 10.1080/02688697.2021.1884648. Epub 2021 Feb 16. Br J Neurosurg. 2024. PMID: 33590799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters